Emergency Medicine Hub / Hematology & Oncology • 3 min read • 2 sections

Acquired Coagulopathies & Anticoagulant Reversal

Comprehensive emergency evaluation and protocolized reversal of life-threatening bleeding from anticoagulant therapies and acquired coagulopathies: Vitamin K antagonists (Warfarin/Coumadin; supratherapeutic INR, oral Vitamin K vs. 4-Factor Prothrombin Complex Concentrate [4F-PCC/Kcentra]); Direct Oral Anticoagulants (DOACs): Factor Xa inhibitors (Apixaban, Rivaroxaban) reversal with Andexanet alfa vs. off-label 4F-PCC; Direct Thrombin Inhibitor (Dabigatran) reversal with Idarucizumab (Praxbind); Unfractionated Heparin and LMWH reversal with IV Protamine Sulfate; and liver disease coagulopathy.

Resuscitation Quick Actions • First 2 Minutes

High-Acuity

Warfarin Life-Threatening Bleed

4F-PCC (Kcentra) 25–50 units/kg IV (max 5,000 units) + Vitamin K 10 mg slow IV in 50 mL NSS over 20 min (FFP is obsolete)

Dabigatran Reversal (Praxbind)

Idarucizumab (Praxbind) 5 grams IV (administered as two consecutive 2.5g IV boluses); immediately binds and inactivates dabigatran

Factor Xa Inhibitor Reversal

Andexanet alfa (Andexxa) weight/timing-based bolus + infusion OR 4F-PCC fixed dose 2,000–3,000 units IV (or 50 units/kg)

IV Vitamin K Must Accompany PCC

4F-PCC factors have half-lives of 6–24 hours; Vitamin K 10 mg IV is MANDATORY to stimulate endogenous hepatic factor synthesis

Heparin Reversal (Protamine)

Protamine Sulfate 1 mg per 100 units of Unfractionated Heparin given in previous 2 hours (max single dose 50 mg; infuse slowly to avoid hypotension)

Asymptomatic High INR (> 10)

No bleeding + INR > 10: Withhold warfarin, administer Oral Vitamin K 2.5 to 5 mg PO; DO NOT give IV Vitamin K (anaphylactoid risk)

Heparin-Induced Thrombocytopenia (HIT) 4T Score

Evaluates Thrombocytopenia magnitude (50% drop), Timing (day 5-10), Thrombosis, and oTher causes; score 6-8 = high risk; stop all heparin, start non-heparin anticoagulant (Argatroban, Bivalirudin, or Fondaparinux).

Bottom-Line Clinical Pearl

In patients presenting with life-threatening hemorrhage (intracranial hemorrhage, massive GI bleed, retroperitoneal hematoma) on anticoagulation, immediate reversal is mandatory. (1) Warfarin (Coumadin): First-line is 4-Factor Prothrombin Complex Concentrate (4F-PCC/Kcentra, containing factors II, VII, IX, X, Protein C & S) dosed by pre-treatment INR (25–50 units/kg IV, max 5,000 units) PLUS IV Vitamin K 10 mg slow IV piggyback (4F-PCC works in 15 minutes but lasts 6–8 hours; Vitamin K sustains hepatic synthesis after 6 hours). Fresh Frozen Plasma (FFP) is INFERIOR (requires 1–2 liters, takes hours to thaw, and causes volume overload/TACO). (2) Dabigatran (Pradaxa): Reversible with Idarucizumab (Praxbind) 5 grams IV (two 2.5g vials). (3) Factor Xa Inhibitors (Apixaban, Rivaroxaban): Reversible with Andexanet alfa (Andexxa) OR 4F-PCC fixed-dose (2,000 units or 50 units/kg IV). (4) Heparin: Protamine Sulfate (1 mg neutralizes 100 units heparin).

1. Warfarin Reversal & The 4-Factor PCC Superiority

Warfarin competitively inhibits vitamin K epoxide reductase (VKORC1), blocking the gamma-carboxylation of vitamin K-dependent clotting factors (II, VII, IX, X) and natural anticoagulant proteins C and S.

Clinical Scenario	Emergency Intervention Regimen	Clinical Rationale & Evidence
Life-Threatening Bleed (Intracranial, Massive GI, Shock)	4-Factor PCC (Kcentra) dosed by pre-treatment INR:<br>- INR 2.0 to < 4.0: 25 units/kg IV (max 2,500 units)<br>- INR 4.0 to 6.0: 35 units/kg IV (max 3,500 units)<br>- INR > 6.0: 50 units/kg IV (max 5,000 units)<br><br>PLUS Vitamin K 10 mg slow IV piggyback over 20–30 min	4F-PCC normalizes INR within 15 to 30 minutes with an infusion volume of only 50–100 mL.<br><br>Why FFP is Obsolete: Fresh Frozen Plasma requires 15–30 mL/kg (1.5 to 2.5 liters of volume!), takes 1–2 hours to thaw and crossmatch, and carries high risk of Transfusion-Associated Circulatory Overload (TACO) and lung injury (TRALI).
INR > 10.0 WITHOUT Bleeding	Withhold warfarin doses; administer Oral Vitamin K 2.5 to 5.0 mg PO	Reverses INR safely over 24–48 hours. Do not give IV Vitamin K (risk of anaphylactoid reactions without clinical benefit when no bleeding is present).
INR 4.5 to 10.0 WITHOUT Bleeding	Withhold next 1 to 2 doses of warfarin; monitor serial INR	Routine vitamin K is NOT recommended; withholding doses achieves safe decline without causing prolonged warfarin resistance.

2. Direct Oral Anticoagulant (DOAC) Reversal Protocols

Anticoagulant Class & Drugs	Specific Reversal Antidote	Alternative/Off-Label Strategy
Dabigatran (Pradaxa) (Oral Direct Thrombin Inhibitor)	Idarucizumab (Praxbind): 5 grams IV (administered as two separate 2.5g IV boluses back-to-back)	Humanized Fab antibody fragment that binds free dabigatran with 350x higher affinity than thrombin. Normalizes clotting within 5 minutes. If unavailable: 4F-PCC 50 units/kg or hemodialysis (dabigatran is 60% dialyzable).
Apixaban (Eliquis) & Rivaroxaban (Xarelto) (Oral Factor Xa Inhibitors)	Andexanet Alfa (Andexxa): Recombinant modified human decoy Factor Xa protein.<br>- Low Dose: 400 mg IV bolus @ 30 mg/min + 4 mg/min infusion x 2h (if last dose $\le 5\text{ mg}$ apixaban or $\le 10\text{ mg}$ rivaroxaban, or $> 8\text{ hours}$ ago)<br>- High Dose: 800 mg IV bolus @ 30 mg/min + 8 mg/min infusion x 2h	4-Factor PCC (Kcentra): Fixed-dose 2,000 units IV OR weight-based 50 units/kg IV.<br>Widely utilized due to extreme acquisition cost ($30,000–$50,000) and thrombotic rebound concerns with andexanet alfa. Supported by major neurocritical care consensus guidelines.

Board & Shelf Drill 5 Questions • Untimed Tutor Mode

Test Your Acquired Coagulopathies & Anticoagulant Reversal Clinical Acumen

Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.

Related Emergency Protocols & Differentials

Related EM Protocol